Filtros de búsqueda

Lista de obras de Yana Pikman

A Prospective Cohort Quality Improvement Study to Reduce the Time to Antibiotics for New Fever in Neutropenic Pediatric Oncology Inpatients

artículo científico publicado en 2015

Advances in the molecular characterization of Philadelphia-negative chronic myeloproliferative disorders

artículo científico publicado en 2007

Exploiting an Asp-Glu "switch" in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemia.

artículo científico publicado en 2018

Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation

artículo científico publicado en 2005

Genetic profiling of myeloproliferative disorders by single-nucleotide polymorphism oligonucleotide microarray

artículo científico publicado en 2008

MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients

artículo científico publicado en 2006

MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia

artículo científico publicado en 2006

Peters anomaly in association with multiple midline anomalies and a familial chromosome 4 inversion

artículo científico publicado en 2006

Pulmonary hypertension associated with scurvy and vitamin deficiencies in an autistic child

artículo científico publicado en 2013

Rapid next-generation sequencing aids in diagnosis of transient abnormal myelopoiesis in a phenotypically normal newborn

artículo científico publicado en 2022

Resistance Mechanisms to SYK Inhibition in Acute Myeloid Leukemia

scientific article published on 26 November 2019

SYK is a critical regulator of FLT3 in acute myeloid leukemia

artículo científico publicado en 2014

Synergistic Drug Combinations with a CDK4/6 Inhibitor in T-cell Acute Lymphoblastic Leukemia

artículo científico publicado en 2016

Targeted therapy for fusion-driven high-risk acute leukemia

scholarly article by Yana Pikman & Kimberly Stegmaier published 20 September 2018 in Blood

Targeting MTHFD2 in acute myeloid leukemia

scientific article published on 20 June 2016

The CDK-activating kinase (CAK) Csk1 is required for normal levels of homologous recombination and resistance to DNA damage in fission yeast

artículo científico publicado en 2008

The Folate Cycle Enzyme MTHFR is a Critical Regulator of Cell Response to MYC-Targeting Therapies

scientific article published on 21 August 2020

The OTT-MAL fusion oncogene activates RBPJ-mediated transcription and induces acute megakaryoblastic leukemia in a knockin mouse model

artículo científico publicado en 2009

The creatine kinase pathway is a metabolic vulnerability in EVI1-positive acute myeloid leukemia

artículo científico publicado en 2017

The menin-MLL1 interaction is a molecular dependency in <i>NUP98</i>-rearranged AML

artículo científico publicado en 2022